April 2026

A natural antioxidant expands its therapeutic potential: from a rare disease to the treatment of other types of stones in the kidney

Cross-disciplinary Program in Adult Rare Diseases, Genes, Disease and Therapy Program, Human Molecular Genetics, Physiology and pathology of the functional relationship between glia and neurons , Translational Medicine Area / By

L-Ergothioneine is presented as a promising therapeutic alternative for different types of nephrolithiasis

A natural antioxidant expands its therapeutic potential: from a rare disease to the treatment of other types of stones in the kidney Read More »

A new oral drug against a rare type of lung cancer that had no clear targeted treatment

Cancer, Cross-disciplinary Program in Adult Rare Diseases, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Preclinical and experimental research in thoracic tumors (PReTT) / By

The new drug stands out for its effectiveness and, above all, low toxicity, avoiding serious pulmonary complications in patients.

A new oral drug against a rare type of lung cancer that had no clear targeted treatment Read More »

A group from CNIO and IDIBELL is making progress in identifying the lesions that will become breast cancer, which may help prevent overtreatment

Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Transformation and Metastasis / By

A new study has found a new marker that identifies precancerous breast lesions that will develop into tumors

A group from CNIO and IDIBELL is making progress in identifying the lesions that will become breast cancer, which may help prevent overtreatment Read More »

Scroll to Top